| ASSET | MONTH | % RETURN |
|---|---|---|
Avalon GloboCare (ALBT) | February 2017 | 10,426.32% |
Ocean Power Technologies (OPTT) | February 2017 | 1,817.6% |
Datasea (DTSS) | February 2017 | 1,000% |
Duos Technologies (DUOT) | February 2017 | 500% |
Worksport (WKSP) | February 2017 | 414.74% |
Castellum (CTM) | February 2017 | 175% |
Atlas Lithium Corporation Common Stock (ATLX) | February 2017 | 150% |
Ryvyl (RVYL) | February 2017 | 126.09% |
Aehr Test Systems (AEHR) | February 2017 | 122.03% |
Esperion Therapeutics (ESPR) | February 2017 | 113.81% |
JX Luxventure (JXG) | February 2017 | 111.75% |
Quoin Pharmaceuticals Ltd DRC (QNRX) | February 2017 | 107.89% |
Pulse Biosciences (PLSE) | February 2017 | 103.64% |
Quantum Computing (QUBT) | February 2017 | 100% |
Netcapital (NCPL) | February 2017 | 100% |
Biovie (BIVI) | February 2017 | 93.51% |
Inotiv (NOTV) | February 2017 | 90.59% |
Galectin Therapeutics (GALT) | February 2017 | 90% |
Gravity (GRVY) | February 2017 | 88.47% |
Pulmatrix (PULM) | February 2017 | 82.22% |
Sangoma Technologies (SANG) | February 2017 | 80% |
Kiora Pharmaceuticals (KPRX) | February 2017 | 73.86% |
Cronos (CRON) | February 2017 | 72.23% |
Protalix Biotherapeutics (PLX) | February 2017 | 72.13% |
Reliance Global (RELI) | February 2017 | 72.09% |
